New & Noteworthy

April 2016

Immunosuppressive Drug Assays

Roche Diagnostics

Roche announces the Elecsys Sirolimus and Everolimus immunosuppressive drug assays. The Elecsys Immunosuppressive drug (ISD) assays offer high precision and consistent results, which are vital factors in helping physicians to correctly tailor immunosuppressive therapy to individual organ transplant patients. With Elecsys ISD assays, the required pretreatment step can be done with only a single procedure and reagent, which brings a clear benefit in terms of testing efficiency and reduction of handling errors. All assays offer performance based on Roche's proven Elecsys electrochemiluminescence (ECL) technology. The tests can be performed on any of the cobas modular platforms, allowing laboratories to consolidate a wide range of assays on a single analytical platform.

Request More Information

Current Issue